Kala Pharmaceuticals (KALA) Reports In-Line Q2 EPS

Go back to Kala Pharmaceuticals (KALA) Reports In-Line Q2 EPS
(NASDAQ: KALA) Delayed: 0.92 +0.04 (4.55%)
Previous Close $0.88    52 Week High
Open $0.97    52 Week Low
Day High $0.97    P/E N/A 
Day Low $0.86    EPS
Volume 103,836